Retinoic acid (RA) can potentiate the antitumor effect of interferons (IFN)
in a variety of tumor types, including renal cell carcinoma (RCC). The mec
hanisms by which RA and IFN increase the antitumor effects in RCC are unkno
wn. We used growth assays and mobility shift assays to examine the effects
of combining 13-cis-retinoic acid (CRA) and IFN-alpha (plus IFN-gamma) on p
roliferation and on the expression of the IFN-specific transcription factor
IFN-stimulated gene factor 3 (ISGF3) in RCC cell lines. Combining CRA and
IFN-alpha resulted in a significant increase in growth inhibition in four c
ell lines compared with IFN-alpha or CRA alone. Binding of nuclear extracts
from RCC cells to an IFN-stimulated response element (ISRE) oligonucleotid
e probe following incubation with IFN-alpha was not increased by CRA but wa
s significantly increased by pretreatment by IFN-gamma in a time-dependent
fashion. Proliferation assays showed that sequential addition of IFN-gamma
and IFN-alpha significantly increased growth inhibition. IFN-alpha but not
IFN-gamma or CRA increased the cellular levels Stat2 and p48 but not Stat1.
IFN-gamma pretreatment enhanced the upregulation of p48 levels by IFN-cu.
Combining RA and IFN results in additive growth inhibition on RCC cell line
s. This increase in growth inhibition is not mediated by increased ISGF3 ex
pression.